Dr Caroline Rudisill is a lecturer in Health Economics at the London School of Economics. She is also Director of the MSc in Health Economics, Policy and Management at the LSE and is a visiting lecturer in Health Economics at King's College London.
Caroline's research interests focus on two main areas. First, how perceptions about risks impact individuals' health care and pharmaceutical choices and the likelihood of uptake in preventative health-related behaviours. She is currently undertaking work on patients' choices around pharmaceutical use including vaccinations against swine flu and the intersection of alcohol policy and perceptions of risk about alcohol consumption.
Second, Caroline is interested in the use of economic evaluation to play a role in coverage decisions in health systems worldwide. This research includes modelling treatment choices and examining the policy implications of economic evaluation results. For example, she is currently involved in an economic evaluation of primary care-led strategies to prevent type II diabetes.
Caroline has undertaken research on pharmaceutical and health financing policy for various consultancies, pharmaceutical companies and international organizations. She was recently the health economics lead on a European Commission-funded project to develop health management training in Serbia.
Caroline holds a PhD in Social Policy (concentration in Health Economics) from the LSE, MSc (with distinction) in International Health Policy (Health Economics) from the LSE and a BA (cum laude) in Economics from Georgetown University in Washington, DC. Prior to coming to the LSE for her MSc, Caroline worked for Goldman Sachs in New York City and at Analysis Group in Washington, DC, an economic consultancy. She has also worked at McKinsey in London serving public and private sector health care clients.
For a full list of Caroline's publications, please see her LSE Research Online Page.